These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 16270380

  • 1. Significance and prognostic value of lysosomal enzyme activities measured in surgically operated adenocarcinomas of the gastroesophageal junction and squamous cell carcinomas of the lower third of esophagus.
    Altorjay A, Paal B, Sohar N, Kiss J, Szanto I, Sohar I.
    World J Gastroenterol; 2005 Oct 07; 11(37):5751-6. PubMed ID: 16270380
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J, Wu N, Zheng QF, Yan S, Lv C, Li SL, Yang Y.
    World J Gastroenterol; 2014 Dec 28; 20(48):18397-403. PubMed ID: 25561808
    [Abstract] [Full Text] [Related]

  • 3. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer.
    Haverkamp L, Seesing MF, Ruurda JP, Boone J, V Hillegersberg R.
    Dis Esophagus; 2017 Jan 01; 30(1):1-7. PubMed ID: 27001442
    [Abstract] [Full Text] [Related]

  • 4. The prognostic importance of pathologically involved celiac node metastases in node-positive patients with carcinoma of the distal esophagus or gastroesophageal junction: a surgical series from the Mayo Clinic.
    Schomas DA, Quevedo JF, Donahue JM, Nichols FC, Romero Y, Miller RC.
    Dis Esophagus; 2010 Apr 01; 23(3):232-9. PubMed ID: 19515184
    [Abstract] [Full Text] [Related]

  • 5. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas.
    Bollschweiler E, Baldus SE, Schröder W, Prenzel K, Gutschow C, Schneider PM, Hölscher AH.
    Endoscopy; 2006 Feb 01; 38(2):149-56. PubMed ID: 16479422
    [Abstract] [Full Text] [Related]

  • 6. VEGF-C expression in squamous cell carcinoma and adenocarcinoma of the esophagus.
    Möbius C, Freire J, Becker I, Feith M, Brücher BLDM, Hennig M, Siewert JR, Stein HJ.
    World J Surg; 2007 Sep 01; 31(9):1768-1772. PubMed ID: 17354029
    [Abstract] [Full Text] [Related]

  • 7. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V, Dreuw B, Ophoff K, Fass J.
    Leber Magen Darm; 1996 Mar 01; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [Abstract] [Full Text] [Related]

  • 8. Results of surgical therapy of adenocarcinomas of the esophagogastric junction according to a standardized surgical resection technique.
    Meyer W, Popp M, Klinger L, Awad-Allah A, Gebhardt C.
    Dig Surg; 2002 Mar 01; 19(4):269-74; discussion 275. PubMed ID: 12207069
    [Abstract] [Full Text] [Related]

  • 9. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
    Griffiths EA, Brummell Z, Gorthi G, Pritchard SA, Welch IM.
    J Surg Oncol; 2006 Mar 15; 93(4):258-67. PubMed ID: 16496364
    [Abstract] [Full Text] [Related]

  • 10. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
    Nakamura M, Iwahashi M, Nakamori M, Naka T, Ojima T, Iida T, Katsuda M, Tsuji T, Hayata K, Mastumura S, Yamaue H.
    Am Surg; 2012 May 15; 78(5):567-73. PubMed ID: 22546130
    [Abstract] [Full Text] [Related]

  • 11. [Predictive value of log odds of positive lymph nodes for the prognosis of patients with node-negative squamous cell carcinoma of the thoracic esophagus after radical esophagectomy].
    Yang M, Zhang H, Huo X, Chen C, Yu Z.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 May 15; 19(5):535-9. PubMed ID: 27215521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT.
    Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Modern esophageal surgery and late functional results as equations with several unknowns--Hungarian Academy of Sciences Doctoral Thesis].
    Altorjay A.
    Magy Seb; 2008 Oct 15; 61(5):285-96. PubMed ID: 19028662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dipeptidyl peptidase IV, prolyl endopeptidase and cathepsin B activities in primary human lung tumors and lung parenchyma.
    Sedo A, Krepela E, Kasafírek E.
    J Cancer Res Clin Oncol; 1991 Oct 15; 117(3):249-53. PubMed ID: 1674512
    [Abstract] [Full Text] [Related]

  • 18. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.
    Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, Wang X, Gao G, Wu TT, Komaki R, Chang JY.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):389-96. PubMed ID: 17236963
    [Abstract] [Full Text] [Related]

  • 19. Squamous cell carcinoma of the esophagus with mucin-secreting component. Mucoepidermoid carcinoma.
    Fegelman E, Law SY, Fok M, Lam KY, Loke SL, Ma LT, Wong J.
    J Thorac Cardiovasc Surg; 1994 Jan 01; 107(1):62-7. PubMed ID: 8283920
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and topography of lymph node metastases in early esophageal and gastric cancer.
    Gertler R, Stein HJ, Schuster T, Rondak IC, Höfler H, Feith M.
    Ann Surg; 2014 Jan 01; 259(1):96-101. PubMed ID: 24096772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.